
GE HealthCare Technologies Inc.
GEHCNASDAQHealthcareMedical - Devices
Previous close
$74.82
+$0.76 · +1.03%
GEHC company overview
Regular session · ET · Market data may be delayed.
GoAI snapshot
AI-powered factor overview
GoAI score
Buy
Favorable setup — positive multi-factor alignment
Valuation
84
Deep Value
Momentum
34
Weakening
Sentiment
63
Bullish
Risk resilience
66
Moderate Risk
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
AI-generated, informational only, and not investment advice.
Company profile
Company websiteGE HealthCare Technologies Inc. is a global medical technology company that creates, manufactures, and markets a diverse range of medical devices, services, and integrated digital solutions. These offerings are designed to assist in the diagnosis, treatment, and ongoing monitoring of patients. The company boasts an extensive international presence, serving markets across the United States, Canada, Europe, the Middle East, Africa, China, Taiwan, Mongolia, and Hong Kong, among other regions. Its operations are structured across four primary business divisions: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The Imaging division specializes in advanced diagnostic imaging technologies, including systems for molecular imaging, Computed Tomography (CT) scans, Magnetic Resonance (MR) imaging, image-guided therapy, and X-ray, alongside specialized women's health products. The Ultrasound segment delivers a comprehensive suite of ultrasound solutions utilized for the screening, diagnosis, treatment, and monitoring of various diseases. These applications span radiology, primary care, women's health, cardiovascular diagnostics, point-of-care, and portable handheld devices, in addition to products supporting surgical visualization and guidance. The Patient Care Solutions segment is dedicated to providing essential medical devices, consumable products, services, and digital platforms. Its portfolio encompasses patient monitoring, anesthesia delivery and respiratory care, diagnostic cardiology, and maternal-infant care products. The Pharmaceutical Diagnostics segment supplies specialized diagnostic agents to the radiology and nuclear medicine industries. These include contrast media pharmaceuticals, administered to patients prior to scans like CT, angiography, X-ray, and MR, to enhance the visibility of internal tissues and structures. It also offers molecular imaging agents, or radiopharmaceuticals – molecular tracers labeled with radioisotopes – injected into patients for advanced diagnostic imaging applications such as Single-Photon Emission Computed Tomography (SPECT), Positron Emission Tomography (PET), and specific ultrasound procedures. Established in 2022, GE HealthCare Technologies Inc. maintains its corporate headquarters in Chicago, Illinois.
- Industry
- Medical - Devices
- Sector
- Healthcare
- Headquarters
- US
- CEO
- Peter J. Arduini
- Listed since
- Dec 15, 2022
- Employees
- 54,000
Market position
Day range
Current $74.82
52-week range
Current $74.82
- Open
- $74.23
- Previous close
- $74.06
- Volume
- 2.25M
- 0.44× average
- Average volume
- 5.13M
- Average daily volume
- Market cap
- 33.8B USD
- Beta
- 0.82
- Market reference 1
- 50-day average
- $66.6559
- +12.25% above average
- 200-day average
- $72.8386
- +2.72% above average
Financials
Financial snapshot
Latest / TTMValuation & yield
- Enterprise value
- 42.93B USD
- P/E (TTM)
- 21.5×
- P/B (TTM)
- 3.09×
- P/S (TTM)
- 1.67×
- EV / EBITDA
- 11.34×
- Earnings yield
- 5.57%
- Free cash flow yield
- 4.02%
- Dividend yield
- 0.19%
Profitability & efficiency
- Gross margin
- 42.90%
- Operating margin
- 12.70%
- Net margin
- 7.86%
- Return on equity
- 20.08%
- Return on assets
- 5.65%
- Return on invested capital
- 8.84%
Financial health
- Debt / equity
- 0.92×
- Current ratio
- 1.18×
Financial statements
Margin trends
Profitability as a percentage of reported revenue.
Income trends
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 20.63B USD | 19.67B USD | 19.55B USD | 18.34B USD | 17.59B USD |
| Cost of goods sold | 12.38B USD | 11.47B USD | 11.63B USD | 11.16B USD | 10.41B USD |
| Gross profit | 8.25B USD | 8.21B USD | 7.92B USD | 7.18B USD | 7.17B USD |
| Research and development | 1.26B USD | 1.31B USD | 1.21B USD | 1.03B USD | 816M USD |
| Selling, general, and administrative | 4.23B USD | 4.27B USD | 4.28B USD | 3.63B USD | 3.56B USD |
| Operating expenses | 5.49B USD | 5.58B USD | 5.49B USD | 4.66B USD | 4.38B USD |
| Interest income | — | — | 26M USD | — | 34M USD |
| Interest expense | 450M USD | 505M USD | 542M USD | 86M USD | 40M USD |
| Depreciation and amortization | 578M USD | 580M USD | 610M USD | 633M USD | 625M USD |
| Operating income | 2.76B USD | 2.63B USD | 2.44B USD | 2.52B USD | 2.8B USD |
| Net income | 2.08B USD | 1.99B USD | 1.57B USD | 1.92B USD | 2.25B USD |
Company facts updated Aug 24, 2026.
Earnings
- EPS beat rate
- 82%
- 9 beats, 2 misses, 0 met estimates
- Average EPS surprise
- +6.31%
- 11 comparable reports
- Latest EPS result
- 1.13
- Estimate 1.04 · Beat by 8.65%
EPS: actual versus estimate
Recent quarterly results
Revenue: actual versus estimate
Recent quarterly results
Analyst ratings
Third-party consensus; not a GoAI recommendation.
Rating distribution
18 ratingsGEHC peers
ETFs holding GEHC
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI985.46M0.04%2.3T USD0.03%$378.24+0.44%
Vanguard S&P 500 ETFVOO812.15M0.05%1.7T USD0.03%$703.71+0.39%
Invesco QQQ Trust, Series 1QQQ725.28M0.15%485.41B USD0.18%$713.44+0.35%
Vanguard Morningstar Mid-Cap ETFVO669.64M0.30%224.7B USD0.03%$82.97+0.53%
iShares Core S&P 500 ETFIVV454.06M0.05%891.84B USD0.03%$769.31+0.39%
State Street SPDR S&P 500 ETFSPY419M0.05%817.87B USD0.09%$765.72+0.41%
Vanguard Morningstar Value ETFVTV294.63M0.11%256.5B USD0.03%$226.4+0.54%
VanEck Morningstar Wide Moat ETFMOAT290.11M2.35%12.46B USD0.46%$114.42+0.95%
Vanguard Morningstar Total Stock Market ETFVTI- Market value
- 985.46M
- Weight
- 0.04%
- AUM
- 2.3T USD
- Expense ratio
- 0.03%
- Price / 1D
- $378.24+0.44%
Vanguard S&P 500 ETFVOO- Market value
- 812.15M
- Weight
- 0.05%
- AUM
- 1.7T USD
- Expense ratio
- 0.03%
- Price / 1D
- $703.71+0.39%
Invesco QQQ Trust, Series 1QQQ- Market value
- 725.28M
- Weight
- 0.15%
- AUM
- 485.41B USD
- Expense ratio
- 0.18%
- Price / 1D
- $713.44+0.35%
Vanguard Morningstar Mid-Cap ETFVO- Market value
- 669.64M
- Weight
- 0.30%
- AUM
- 224.7B USD
- Expense ratio
- 0.03%
- Price / 1D
- $82.97+0.53%
iShares Core S&P 500 ETFIVV- Market value
- 454.06M
- Weight
- 0.05%
- AUM
- 891.84B USD
- Expense ratio
- 0.03%
- Price / 1D
- $769.31+0.39%
State Street SPDR S&P 500 ETFSPY- Market value
- 419M
- Weight
- 0.05%
- AUM
- 817.87B USD
- Expense ratio
- 0.09%
- Price / 1D
- $765.72+0.41%
Vanguard Morningstar Value ETFVTV- Market value
- 294.63M
- Weight
- 0.11%
- AUM
- 256.5B USD
- Expense ratio
- 0.03%
- Price / 1D
- $226.4+0.54%
VanEck Morningstar Wide Moat ETFMOAT- Market value
- 290.11M
- Weight
- 2.35%
- AUM
- 12.46B USD
- Expense ratio
- 0.46%
- Price / 1D
- $114.42+0.95%
Continue in GoAI
Research GEHCresearch.disclaimer





